You searched for "ORL"

696 results found

OBITUARY: Max McCormick

It is with great sadness that we record the passing of Max McCormick, a treasured friend and an eminent and greatly valued colleague. Max was a larger-than-life charismatic character who was both loved and esteemed by the entire UK ENT...

From the editor January/February 2024

Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTw: @Voicedoctor_uk Welcome to January/February 2024 – I hope you have had a restful Christmas break and that you are raring to go...

From the editor Jan/Feb 2025

Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTW / X: @Voicedoctor_uk As we slip seamlessly into the new year, I hope you have all had a good break and that...

EROC 2025

Professor Hesham Negm, Faculty of Medicine, Cairo University The 14th edition of the Emirates Rhinology & Otology Conference (EROC) Global Forum 2025 concluded successfully, drawing over 3056 delegates from more than 120 countries and featuring more than 100 distinguished international...

ESPO 2025

Ayla TabaksertOver 1000 paediatric ENT specialists from 68 countries said “Guten tag!” as they convened for the 17th Congress of the European Society of Paediatric Otorhinolaryngology (ESPO 2025) at the International Congress Centre, Stuttgart. In a city known for world-class...

ESPO Marseille 2020

The biennial ESPO meetings have established themselves as the premier forum for paediatric otolaryngologists to share their knowledge and research. Hardly has ESPO Stockholm finished, and plans are already underway for ESPO 2020. Jean-Michel Triglia and Richard Nicollas and tell...

The role of the maxillo-facial surgeon in the management of skull base malignancy

Whilst ablative surgery remains the principal treatment option for head and neck malignancy, the skull base is the last frontier. The complex anatomy, supreme functionality of the brain, and varied pathology provokes many a detailed discussion in the multidisciplinary team...

The lateral neck cystic mass – diagnostic dilemma. Can HPV status help?

Solitary cystic masses in the lateral neck can present a significant diagnostic dilemma as they can be metastases from tumours of the oro or nasopharynx. This retrospective paper detailed all patients presenting to a university hospital in Germany, from September...

Does transoral robotic surgery improve outcomes among patients with head and neck cancer of unknown primary?

A tonsillectomy and tongue base mucosectomy is becoming increasingly accepted as the optimal surgical intervention to aid in identifying the primary source of a p16+ / HPV-related squamous cell carcinoma (SCC) of unknown origin, given that this disease almost exclusively...

Monitored safe medical practice: minimising patient harm will reduce medical negligence bill for the NHS

Patrick Bradley ruminates on a celebrated career in ENT head and neck surgery and suggests that increasing the possibility of positive outcomes to contemporary patient safety initiatives by the NHS must involve efforts to develop an enthusiastic contented workforce willing...

Malignant transformation of leukoplakia in previous cancer patients

This is a retrospective study from Taiwan assessing risk factors in developing oral squamous cell carcinoma from surgically excised oral leukoplakia in patients with a previous oral cancer, the underlying thought being that patients with an oral carcinoma have a...

Systemic agents in thyroid cancer

For those patients who have disseminated or unresectable thyroid cancer, Dr Arabella Hunt and Dr Kate Newbold review systemic treatments, their differences, toxicities and outcomes. Thyroid cancer is the most common endocrine malignancy. It is subdivided into differentiated (papillary, follicular...